Final hours! Save up to 55% OFF InvestingProCLAIM SALE

MyHealthChecked issues new shares after options exercise

Published 12/23/2024, 06:58 AM

LONDON - MyHealthChecked PLC (AIM: MHC), a UK-based consumer home-testing healthcare company, has announced the issuance of 30,000 new ordinary shares following the exercise of options. The shares, each with a nominal value of 1.5p, were allotted on Monday, December 20, 2024, under the company's existing allotment authorities.

The options were exercised at a price of 9.5 pence per share. The new ordinary shares are expected to be admitted to trading on the London Stock Exchange (LON:LSEG)'s AIM market at 8.00 am on or around December 31, 2024, and will rank equally in all respects with the existing ordinary shares of the company.

Following the admission of the new shares, MyHealthChecked's total issued share capital will consist of 52,035,932 ordinary shares. Consequently, the total number of voting rights in the company will also be 52,035,932, which shareholders can use as the denominator for calculations related to their interest notifications under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

MyHealthChecked specializes in a variety of at-home healthcare and wellness tests. Their portfolio includes lateral-flow self-tests and sample collection kits for DNA, RNA, and blood, which are analyzed by partner laboratories. These products aim to cater to a growing market of consumers seeking accessible healthcare options.

The company has made its products available online and for over-the-counter purchase, positioning itself within the evolving at-home testing kit market that emphasizes affordability and expertise from UK-based professionals.

This development is based on a press release statement and reflects the company's ongoing efforts to manage its share capital effectively. The information provided does not imply an endorsement of the company's market position or future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.